Clinical Trial Update: Longitudinal Study of Mitochondrial Hepatopathies

View source ↗

Summary

The longitudinal study of mitochondrial hepatopathies is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorders of Fatty Acid Oxidation
• End-stage Liver Disease
• Liver Failure
• Mitochondrial Diseases
• Mitochondrial Respiratory Chain Deficiencies

Snippet

Sponsor: Arbor Research Collaborative for Health | Conditions: Acute Liver Failure, Mitochondrial Diseases | Status: SUSPENDED